Pregnant women in Appalachia face barriers to opioid treatment
July 26, 2018
A NIDA-funded study has discovered that pregnant women in Appalachia face barriers to receiving medication-assisted treatment for opioid use disorders, from both insurers and providers. Investigators looked at the availability of methadone, an opioid agonist treatment, as well as buprenorphine, which is a partial agonist. Appalachian states have disproportionately higher rates of opioid use. The investigators provided an infographic to explain highlights of their findings, including data from a survey of opioid agonist therapy (OAT) providers.